Avenue Therapeutics, Inc.

ATXI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1$0-$2-$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$1
Change in WC$0-$1$0-$0
Other Non-Cash$1-$0$0$0
Operating Cash Flow$0-$0-$1-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$2$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$2$1
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0$1-$0
Supplemental Information
Beg. Cash$3$4$3$3
End Cash$4$3$4$3
Free Cash Flow$0-$0-$1-$1
Avenue Therapeutics, Inc. (ATXI) Financial Statements & Key Stats | AlphaPilot